Lake Street Capital Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $8.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective cut by Lake Street Capital from $13.00 to $8.00 in a report issued on Friday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other brokerages also recently commented on BIOX. Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $9.50 to $7.00 and set a “buy” rating on the stock in a research report on Friday. Oppenheimer cut their price target on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 28th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $10.00.

Bioceres Crop Solutions Stock Down 0.5 %

Shares of NASDAQ BIOX opened at $5.55 on Friday. Bioceres Crop Solutions has a 12-month low of $5.50 and a 12-month high of $14.05. The stock has a market cap of $348.04 million, a P/E ratio of 277.64 and a beta of 0.57. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. The business’s fifty day simple moving average is $6.65 and its 200-day simple moving average is $7.86.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The company had revenue of $92.60 million during the quarter, compared to analysts’ expectations of $117.15 million. During the same quarter in the previous year, the business posted ($0.07) EPS. As a group, equities analysts predict that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Fourth Sail Capital LP grew its holdings in shares of Bioceres Crop Solutions by 61.6% during the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after purchasing an additional 1,209,277 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after purchasing an additional 29,693 shares during the period. Stifel Financial Corp grew its stake in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after buying an additional 10,224 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after buying an additional 5,341 shares during the period. Finally, Ping Capital Management Inc. lifted its stake in Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after buying an additional 3,000 shares during the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.